Syngene International is currently trading at Rs. 610.70, up by 4.15 points or 0.68% from its previous closing of Rs. 606.55 on the BSE.
The scrip opened at Rs. 611.25 and has touched a high and low of Rs. 626.00 and Rs. 602.35 respectively. So far 47217 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 699.95 on 16-Jul-2021 and a 52 week low of Rs. 490.35 on 19-Mar-2021.
Last one week high and low of the scrip stood at Rs. 632.00 and Rs. 589.30 respectively. The current market cap of the company is Rs. 24967.62 crore.
The promoters holding in the company stood at 70.42%, while Institutions and Non-Institutions held 18.89% and 10.68% respectively.
Syngene International has extended its long-standing multi-discipline research collaboration with Amgen Inc, one of the world’s leading biotechnology companies. The contract is currently extended until the end of 2026 and its scope includes integrated drug discovery and development solutions in discovery chemistry and biology, peptide chemistry, antibody and protein reagents, pharmacokinetics and drug metabolism, and pharmaceutical development. In addition to operating the existing Syngene Amgen R&D Center (SARC), under the new contract, Syngene will also build and operate a dedicated laboratory which will enable R&D project acceleration.
Syngene International is India’s largest Contract Research Services Organization providing integrated discovery and development services for novel molecules across multiple platforms including small molecules, large molecules, Antibody-Drug Conjugates and Oligonucleotides.
Company Name | CMP |
---|---|
Syngene Internation. | 869.40 |
Sagility India | 28.03 |
AGS Transact Tech | 79.99 |
Just Dial | 1073.50 |
Krystal Integrated | 643.20 |
View more.. |